Studies have thus far found only limited benefits from remdesivir.
Author Archives: Leslie Cardé
Posted inCoronavirus
Medical experts offer advice on the risks of common activities in phase one
How safe is the beach? Restaurants? Church? The Lens talks with doctors about how (or whether) people can participate safely in the gradual reopening.
Posted inCoronavirus
Doctors urge caution as state enters phase one of reopening
‘Phase one doesn’t mean it’s 100 percent safe,’ said a state Health Department official.
Posted inCoronavirus
Scientists race for vaccine, but still struggle to understand how new virus works
New complications seen in a small number of children just one recent wrinkle in learning about what COVID-19 does.
Posted inCoronavirus
Studies show link between pollution and COVID-19 mortality
Following a Harvard study showing a correlation between COVID-19 mortality and pollution, the Tulane Environmental Law Clinic shows the link in Louisiana’s most polluted parishes.
Posted inCoronavirus
As officials consider plans for reopening, many unanswered questions remain
‘We’ve become aware of just how much we don’t know pertaining to this particular virus,’ one doctor told The Lens.
Posted inCoronavirus
At hospitals and on the curb, pandemic leads to more medical waste
How waste contractors are dealing with heavier, more hazardous loads.
Posted inCoronavirus
The path to reopening: More testing, contact tracing needed to safely restart the state
The governor hopes to begin the reopening process soon, but the state says it still needs hundreds of workers to implement a contact tracing program.
Posted inCoronavirus
Scientists at Tulane National Primate Research Center studying vaccines, treatments for COVID-19
Testing on primates with DNA similar to humans is key to developing new drugs and getting them approved.
Posted inCoronavirus
New Orleans-area hospitals, researchers find new ways to address testing delays and limited drug supplies during COVID-19 crisis
Area healthcare workers develop faster testing methods, new ventilator techniques and participate in trials for potential treatments.